Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Meng

Showing results (401-410 of 440) with videos related to

Pageof 44
Sort By:
International Immunopharmacology|July 14, 2022
miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-βXin Chen, Sai Zhu, Si-Yu Chen, et al.
Frontiers in Pharmacology|February 15, 2021
The Role of IL-35 in the Pathophysiological Processes of Liver DiseaseShuang Hu, Pan-Pan Lian, Ying Hu, et al.
Nature Communications|August 1, 2019
A high-speed search engine pLink 2 with systematic evaluation for proteome-scale identification of cross-linked peptidesZhen-Lin Chen, Jia-Ming Meng, Yong Cao, et al.
Clinical Science (London, England : 1979)|July 19, 2019
RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stressJia-Nan Wang, Ming-Ming Liu, Fang Wang, et al.
Clinical Science (London, England : 1979)|July 9, 2020
DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathwayHai-Di Li, Xin Chen, Jie-Jie Xu, et al.
European Journal of Pharmacology|July 10, 2024
SFN promotes renal fibrosis via binding with MYH9 in chronic kidney diseaseFang Wang, Xiao-Guo Suo, Jia-Nan Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2023
Novel insights into STAT3 in renal diseasesJu-Tao Yu, Shuai Fan, Xiang-Yu Li, et al.
Oncotarget|December 20, 2015
TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosisShuang Wang, Xiao-Ming Meng, Yee-Yung Ng, et al.
European Journal of Pharmacology|July 5, 2022
Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosisXiao-Guo Suo, Fang Wang, Chuan-Hui Xu, et al.
International Immunopharmacology|September 27, 2022
RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammationChuan-Hui Xu, Jia-Nan Wang, Xiao-Guo Suo, et al.
Pageof 44

Showing results (401-410 of 440) with videos related to

Sort By:
Pageof 44
International Immunopharmacology|July 14, 2022
miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-βXin Chen, Sai Zhu, Si-Yu Chen, et al.
Frontiers in Pharmacology|February 15, 2021
The Role of IL-35 in the Pathophysiological Processes of Liver DiseaseShuang Hu, Pan-Pan Lian, Ying Hu, et al.
Nature Communications|August 1, 2019
A high-speed search engine pLink 2 with systematic evaluation for proteome-scale identification of cross-linked peptidesZhen-Lin Chen, Jia-Ming Meng, Yong Cao, et al.
Clinical Science (London, England : 1979)|July 19, 2019
RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stressJia-Nan Wang, Ming-Ming Liu, Fang Wang, et al.
Clinical Science (London, England : 1979)|July 9, 2020
DNMT3b-mediated methylation of ZSWIM3 enhances inflammation in alcohol-induced liver injury via regulating TRAF2-mediated NF-κB pathwayHai-Di Li, Xin Chen, Jie-Jie Xu, et al.
European Journal of Pharmacology|July 10, 2024
SFN promotes renal fibrosis via binding with MYH9 in chronic kidney diseaseFang Wang, Xiao-Guo Suo, Jia-Nan Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2023
Novel insights into STAT3 in renal diseasesJu-Tao Yu, Shuai Fan, Xiang-Yu Li, et al.
Oncotarget|December 20, 2015
TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosisShuang Wang, Xiao-Ming Meng, Yee-Yung Ng, et al.
European Journal of Pharmacology|July 5, 2022
Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosisXiao-Guo Suo, Fang Wang, Chuan-Hui Xu, et al.
International Immunopharmacology|September 27, 2022
RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammationChuan-Hui Xu, Jia-Nan Wang, Xiao-Guo Suo, et al.
Pageof 44